跳至主要内容
临床试验/ISRCTN31328643
ISRCTN31328643已完成未知

A comprehensive study of the efficacy and safety of Licochalcone A , Glycyrrhetinic acid and L-Carnitine containing sun block in the management of acne and post acne pigmentation among Malaysian patients : A randomized, double blinded, comparator controlled trial

Beiersdorf (Malaysia)0 个研究点目标入组 50 人开始时间: 2022年10月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38152154/ (added 06/08/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Males and females with acne vulgaris aged =18 years old
  • 2. Clinically diagnosed by dermatologist as acne vulgaris on the face with
  • 2.1. Inflammatory lesion (papules and pustules) of <25
  • 2.2. Non inflammatory lesions (open or close comedones of <50)
  • 3. Patient must have post acne pigmentation with at least a PAHPI score of 6

排除标准

  • 1. Other forms of acne (acne conglobata, acne excoriate, acne rosacea, acne cosmetica, pomade acne, acne fulminans, acne keloidalis nuchae, acne chloracne, acne mechanica and acne medicamentosa)
  • 2. Nodulocystic acne
  • 3. CASS 4-5
  • 4. On oral antibiotic for the last 1 months
  • 5. On oral isotretinoin for the last 6 months
  • 6. On topical antimicrobial or tretinoin for the last 2 weeks
  • 7. Photosensitivity
  • 8. If patient is currently pregnant or lactating
  • 9. Other comorbidities that require any route of medication commencement (i.e hypertension, diabetes, dyslipidemia, bronchial asthma)
  • 10. If there is any known allergy to the active ingredients in the preparation
  • 11. Patients who have any other facial dermatoses
  • 12. Patients who like outdoor activities and couldn’t comply to sunprotection.

研究者

发起方
Beiersdorf (Malaysia)

相似试验